Israeli startup RedC Biotech aims to replace donors with lab-grown blood from stem cells
RedC Biotech says its lab-grown blood could prevent the deaths of 2 million people a year, solving shortages that leave hospitals worldwide without safe, reliable supplies during emergencies, wars and disasters